Gain Therapeutics Inc. (GANX)

GANX trades at $1.79, 79.0% above the near-term max pain of $1 expiring Sep 19, 2025 (32 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($1-$1), indicating stable market expectations. Key magnetic zone at 1 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for GANX shows stable levels around 1.00, reflecting balanced market expectations. The 0% spread suggests strong consensus on fair value. Most levels below 1.79 may cap rallies. Strong magnetic level at 1 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.